Study Finds Coffee Linked to Lower Death and Recurrence Risk in Colorectal Cancer Patients
Creatrip Team
a month ago
A South Korean observational study of 5,442 colorectal cancer patients found that higher daily coffee intake was associated with better long-term outcomes. Each additional cup per day was linked to about a 4% reduction in risk of death or cancer recurrence; drinking three cups daily corresponded to roughly a 12% reduction. The effect was strongest in stage III patients, with mortality risk reduced by over 40% in that group. Benefits were observed for both caffeinated and decaffeinated coffee, suggesting the protective role of multiple bioactive compounds in coffee (e.g., chlorogenic acid, polyphenols, diterpenes) rather than caffeine alone. Researchers say the findings offer evidence to inform survivorship care and lifestyle guidance but note that further studies are needed to confirm causality. The study was published online in Cancer Epidemiology, Biomarkers & Prevention (CEBP).
